The effectiveness of oral hypoglycemic agents in nonalcoholic fatty liver disease patients with type 2 diabetes mellitus. -Multiple comparison, Dapagliflozin, Pioglitazone vs Glimepiride-
Latest Information Update: 09 Oct 2018
At a glance
- Drugs Dapagliflozin (Primary) ; Glimepiride (Primary) ; Pioglitazone (Primary)
- Indications Non-alcoholic fatty liver disease; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 02 Oct 2018 Status changed from active, no longer recruiting to completed.
- 02 Sep 2017 Status changed from recruiting to active, no longer recruiting.
- 17 May 2016 New trial record